|
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC? |
|
|
|
Titel: |
A phase-II study based on dose adjustment according to UGT1A1 polymorphism: is irinotecan underdosed in first-line FOLFIRI regimen for mCRC? |
Auteur: |
Ginzac, Angeline Thivat, Emilie Petorin, Caroline Richard, Damien Herviou, Pauline Molnar, Ioana Devaud, Hervé Creveaux, Isabelle Ferrer, Florent Authier, Nicolas Jary, Marine Pezet, Denis Durando, Xavier |
Verschenen in: |
Cancer, chemotherapy and pharmacology |
Paginering: |
Jaargang 93 () nr. 3 pagina's 225-236 |
Jaar: |
2023-11-07 |
Inhoud: |
|
Uitgever: |
Springer Berlin Heidelberg, Berlin/Heidelberg |
Bronbestand: |
Elektronische Wetenschappelijke Tijdschriften |
|
|
|
|